Method for treating hepatitis virus infection

作者: Lawrence M. Blatt

DOI:

关键词:

摘要: The present invention provides methods of treating a hepatitis virus infection, particularly C the method generally involving administering to an individual having infection effective amount Type I interferon receptor agonist that is not modified with poly(ethylene glycol) (PEG) moiety, for period time sufficient reduce serum viral load undetectable levels; followed by PEG achieve sustained response.

参考文章(12)
Stephanos J Hadziyannis, George V Papatheodoridis, Peginterferon-?2a (40kDa) for chronic hepatitis C Expert Opinion on Pharmacotherapy. ,vol. 4, pp. 541- 551 ,(2003) , 10.1517/EOPH.4.4.541.22236
P. J. Pockros, R. Reindollar, J. McHutchinson, R. Reddy, T. Wright, D.G. Boyd, L.B. Wilkes, The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients Journal of Viral Hepatitis. ,vol. 10, pp. 55- 60 ,(2003) , 10.1046/J.1365-2893.2003.00402.X
Juan Armendariz-Borunda, M Cristina Islas-Carbajal, Eduardo Meza, Ana Rosa Rincon, Arnulfo Alvarez, Zachary D Goodman, A Soledad Sandoval, Amador Covarrubias, Juan I Menchaca, Gil Arechiga, Leonel García, 314 A pilot study of a novel anti-inflammatory and anti-fibrotic agent, pirfenidone, in patients with liver cirrhosis Hepatology. ,vol. 38, pp. 308- 308 ,(2003) , 10.1016/S0270-9139(03)80357-9
Kenneth E. Sherman, Maria Sjogren, Robin L. Creager, Melissa A. Damiano, Stephen Freeman, Scot Lewey, Dirk Davis, Spencer Root, Frederick L. Weber, Kamal G. Ishak, Zachary D. Goodman, Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo‐controlled double‐blind trial Hepatology. ,vol. 27, pp. 1128- 1135 ,(1998) , 10.1002/HEP.510270430
G. Saracco, A. Olivero, A. Ciancio, S. Carenzi, M. Rizzetto, Therapy of chronic hepatitis C: a critical review. Current Drug Targets - Infectious Disorders. ,vol. 3, pp. 25- 32 ,(2003) , 10.2174/1568005033342127
Youla S. Tsantrizos, Elise Ghiro, Jean Rancourt, Montse Llinas-Brunet, Marc-Andre Poupart, Anne-Marie Faucher, Dale R. Cameron, Murray D. Bailey, Dominik M. Wernic, Teddy Halmos, Nathalie Goudreau, Hepatitis C inhibitor tri-peptides ,(1999)
Carlo Nalin, Perry Rosen, Robert Karasiewicz, PEG-interferon conjugates ,(1993)
Malcolm Maccoss, Phillip Dan Cook, Neelima Bhat, Balkrishen Bhat, Anne B. Eldrup, Marija Prhavc, Steven S. Carroll, David B. Olsen, Quanlai Song, Thazha P. Prakash, Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase ,(2002)